Literature DB >> 31147322

Rethinking primary care user fees: is charging a fee for appointments a solution to NHS underfunding?

Geva Greenfield1, Buland Majeed1, Benedict Hayhoe1, Salman Rawaf1, Azeem Majeed1.   

Abstract

Mesh：

Year:  2019        PMID： 31147322      PMCID： PMC6532806          DOI： 10.3399/bjgp19X703793

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  8 in total

1.  Should patients pay to see the GP?

Authors:  David Jones; Nancy Loader
Journal:  BMJ       Date:  2016-01-06

2.  Consultation charges in Ireland deter a large proportion of patients from seeing the GP: results of a cross-sectional survey.

Authors:  Dermot O'Reilly; Tom O'Dowd; Karen J Galway; Andrew W Murphy; Ciaran O'Neill; Ethna Shryane; Keith Steele; Gerry Bury; Andrew Gilliland; Alan Kelly
Journal:  Eur J Gen Pract       Date:  2007       Impact factor: 1.904

Review 3.  Does charging different user fees for primary and secondary care affect first-contacts with primary healthcare? A systematic review.

Authors:  Thomas Hone; John Tayu Lee; Azeem Majeed; Lesong Conteh; Christopher Millett
Journal:  Health Policy Plan       Date:  2017-06-01       Impact factor: 3.344

4.  Unintended consequences of caps on Medicare drug benefits.

Authors:  John Hsu; Mary Price; Jie Huang; Richard Brand; Vicki Fung; Rita Hui; Bruce Fireman; Joseph P Newhouse; Joseph V Selby
Journal:  N Engl J Med       Date:  2006-06-01       Impact factor: 91.245

5.  Germany: Health system review.

Authors:  Reinhard Busse; Miriam Blümel
Journal:  Health Syst Transit       Date:  2014

6.  Hungary health system review.

Authors:  Peter Gaal; Szabolcs Szigeti; Marton Csere; Matthew Gaskins; Dimitra Panteli
Journal:  Health Syst Transit       Date:  2011

7.  Patient Cost-Sharing and Hospitalization Offsets in the Elderly.

Authors:  Amitabh Chandra; Jonathan Gruber; Robin McKnight
Journal:  Am Econ Rev       Date:  2010-03-01

8.  Effects of a limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia.

Authors:  S B Soumerai; T J McLaughlin; D Ross-Degnan; C S Casteris; P Bollini
Journal:  N Engl J Med       Date:  1994-09-08       Impact factor: 91.245
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.